RBC Europe’s Arena Pharmaceuticals Inc ARNA Stock Holding History

RBC Europe’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-65	Closed	-$3.87K	–	1268
2021 Q3	$3.87K	Hold	65	–	–	﹤0.01%	1064
2021 Q2	$4.43K	Hold	65	–	–	﹤0.01%	1052
2021 Q1	$4.51K	Hold	65	–	–	﹤0.01%	1007
2020 Q4	$4.99K	Hold	65	–	–	﹤0.01%	973
2020 Q3	$4.86K	Hold	65	–	–	﹤0.01%	909
2020 Q2	$4.09K	Hold	65	–	–	﹤0.01%	888
2020 Q1	$2.73K	Hold	65	–	–	﹤0.01%	885
2019 Q4	$2.95K	Hold	65	–	–	﹤0.01%	939
2019 Q3	$2.98K	Hold	65	–	–	﹤0.01%	935
2019 Q2	$3.81K	Hold	65	–	–	﹤0.01%	943
2019 Q1	$2.91K	Hold	65	–	–	﹤0.01%	973
2018 Q4	$2.53K	Hold	65	–	–	﹤0.01%	982
2018 Q3	$2.99K	Buy	+65	New	+$2.63K	﹤0.01%	1020

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RBC Europe's ARNA Position: Q4 2021 in Review

RBC Europe sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 65 shares — an estimated $3.87K sold.

RBC Europe first reported a position in ARNA in Q3 2018 and held it in 13 quarters. The position peaked at $4.99K in Q4 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

RBC Europe reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 65 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $3.87K.
RBC Europe first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 13 quarters.
RBC Europe's Arena Pharmaceuticals Inc position peaked at $4.99K in Q4 2020.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.